The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
Publications
Daptomycin-induced eosinophilic pneumonia: Are there any risk factors?
Infectious diseases now 2021 Jan 09;; — 2021 Jan 09
Imipenem/cilastatin-induced acute eosinophilic pneumonia.
BMJ case reports 2016 Mar 04;2016; — 2016 Mar 04
Dapsone induced eosinophilic pneumonia.
European annals of allergy and clinical immunology 2012 Jun;44;144-6 — 2012 Jun — 144-6
A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.
Infection 2011 Dec;39;583-5 — 2011 Dec — 583-5
Piperacillin-associated pulmonary infiltrates with eosinophilia: a case report.
Canadian respiratory journal 2010 Mar-Apr;17;e24-6 — 2010 Mar-Apr — e24-6
Minocycline pneumonitis and eosinophilia. A report on eight patients.
Archives of internal medicine 1994 Jul 25;154;1633-40 — 1994 Jul 25 — 1633-40